SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001835567-22-000059
Filing Date
2022-07-25
Accepted
2022-07-25 16:01:23
Documents
14
Period of Report
2022-07-25
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K pear-20220725.htm   iXBRL 8-K 41454
6 pear-20220725_g1.jpg GRAPHIC 650556
  Complete submission text file 0001835567-22-000059.txt   1767011

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pear-20220725.xsd EX-101.SCH 2328
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pear-20220725_def.xml EX-101.DEF 19915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pear-20220725_lab.xml EX-101.LAB 37727
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pear-20220725_pre.xml EX-101.PRE 20420
8 EXTRACTED XBRL INSTANCE DOCUMENT pear-20220725_htm.xml XML 15235
Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Filer) CIK: 0001835567 (see all company filings)

IRS No.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39969 | Film No.: 221103312
SIC: 8000 Services-Health Services